The lncRNA SPRY4 intronic transcript 1(SPRY4-IT1) was recently identified in melanoma, and increased expression of SPRY4-IT1 was closely associated with tumor site and tumor stage, which indicated the prognostic role of SPRY4-IT1 in patients with melanoma [10, 11]. This evidence concerns the gene HAUS3 and neoplasm.